
Feintool International Holding AG, together with its subsidiaries, provides fineblanked, formed steel components, and punched electro sheet metal products in Switzerland, rest of Europe, Germany, the United States, Japan, and China. It operates through two segments, System Parts and Fineblanking Technology. The System Parts segment develops, produces, and sells high-precision system components and assemblies using fineblanking and forming technology, as well as electronic sheet stamping; and sells production-specific tools to third-party customers. The Fineblanking Technology segment engages in the development, manufacture, and sale of presses, tools, peripheral systems, and various related services. It provides its products for use in automobile industry, such as engine, chassis, transmission, safety systems, peripheral drives, and seat mechanisms applications, as well as for application in mechanical engineering, power generation, electric motors and drives, tools and household, and medical technology. The company was founded in 1959 and is headquartered in Lyss, Switzerland. Feintool International Holding AG is a subsidiary of Artemis Beteiligungen I AG.
Feintool International Holding AG trades as FEIOF on OTC. The company is classified in Industrials / Manufacturing - Metal Fabrication and reports in USD.
The current profile places the business in Manufacturing - Metal Fabrication. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Latest available fiscal data shows $661.39M of revenue and -$8.02M of net income.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Feintool International Holding AG can be compared against peers such as Chen Hsong Holdings Limited, NHOA S.a., Fullshare Holdings Limited, Globaltrans Investment Plc, Ichinen Holdings Co., Ltd., Lycopodium Limited.
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $309.73M, beta of 0.65, and return on equity of -1.9%.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
FEIOF currently shows total debt of $140.31M and beta of 0.65. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.feintool.com
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.